RxDoctor Payments Data

Bob William, MD

Family Medicine · Plainfield, ILNPI 1114111028

Payments from drug & device makers

$562in general payments, 2019–2025

Across 47 payments — averaging $11.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$353
  • Johnson & Johnson$62
  • Abbott$48
  • AstraZeneca$38
  • Amarin Pharma, Inc.$26
  • Pfizer$21
  • plus $14 from 1 others

What the payments were for

  • Food & beverage$51692%
  • Education$468%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)36$353
Johnson & Johnson2$62
Abbott2$48
AstraZeneca3$38
Amarin Pharma, Inc.2$26
Pfizer1$21
Amgen1$14

How this compares

$562 in reported general payments places this provider in the 65th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$95,901
Medicare patients
240
Services billed
967

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban127$51,040
MounjaroTirzepatide27$37,562
OzempicSemaglutide30$37,059
RybelsusSemaglutide26$29,962
JardianceEmpagliflozin21$28,283
JanuviaSitagliptin Phosphate56$20,478
LinzessLinaclotide17$12,711
MyrbetriqMirabegron11$8,542
Bydureon BciseExenatide Microspheres11$7,824
XanaxAlprazolam12$6,862
Fluticasone-SalmeterolFluticasone Propion/Salmeterol33$6,808
GemtesaVibegron24$6,007
XareltoRivaroxaban15$5,790
AbrysvoRsv Vacc, Pref A And Pref B/Pf16$5,114
Atorvastatin Calcium355$4,201

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Abrysvo$21$56,154143 claims
AbbVieLinzess$353$12,71117 claims
Johnson & JohnsonXarelto$62$5,79015 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Plainfield

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →